Hansa Biopharma AB (publ) (STO:HNSA)
Sweden · Delayed Price · Currency is SEK 29.48
+0.48 (1.66%)
Aug 14, 2025, 5:29 PM CET
Hansa Biopharma AB Employees
Hansa Biopharma AB had 135 employees as of December 31, 2024. The number of employees decreased by 33 or -19.64% compared to the previous year.
Employees
135
Change (1Y)
-33
Growth (1Y)
-19.64%
Revenue / Employee
1.40M SEK
Profits / Employee
-4.26M SEK
Market Cap
2.50B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 135 | -33 | -19.64% |
| Dec 31, 2023 | 168 | 18 | 12.00% |
| Dec 31, 2022 | 150 | 19 | 14.50% |
| Dec 31, 2021 | 131 | 44 | 50.57% |
| Dec 31, 2020 | 87 | 13 | 17.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Swedish Orphan Biovitrum AB | 1,806 |
| Sectra AB | 1,296 |
| Getinge AB | 11,791 |
| Medicover AB | 47,256 |
| Asker Healthcare Group AB | 4,030 |
| Camurus AB | 256 |
| Bonesupport Holding AB | 139 |
| AddLife AB | 2,181 |
Hansa Biopharma AB News
- 16 days ago - Hansa Biopharma announces key executive appointments to support continued growth - PRNewsWire
- 4 weeks ago - Hansa Biopharma AB (publ) 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 4 weeks ago - Hansa Biopharma AB (publ) (HNSBF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Hansa Biopharma Reports Second Quarter and Interim January-June 2025 Financial Results - PRNewsWire
- 5 weeks ago - Hansa Biopharma appoints Dr Richard Philipson as Chief Medical Officer - PRNewsWire
- 6 weeks ago - Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London - PRNewsWire
- 2 months ago - Hansa Biopharma to attend BIO International Convention - PRNewsWire
- 2 months ago - Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025 - PRNewsWire